Positive results for Buvidal® in treatment for fentanyl dependence
New positive results from a Phase 3 study show that Camurus’ Buvidal® provides better treatment effect for fentanyl abuse, among other things, compared to other standard treatments as well as lower withdrawal and drug craving.
New positive results from a Phase 3 study show that Camurus’ Buvidal® provides better treatment effect for fentanyl abuse, among other things, compared to other standard treatments as well as lower withdrawal and drug craving.
Read more at Camurus’ website: https://www.camurus.com/pressreleases/
Latest news
2015-11-19
Camurus to be listed on Nasdaq Stockholm
Camurus announces initial public offering on Nasdaq Stockholm. The company plans a new shares issue to a value of SE…